Beauty Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Beauty Press Releases.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on November 3, 2025

November 3, 2025

Mira Aesthetic Cosmetic Surgery Center Supports Local Athletics with Charitable Donation to Corona del Mar High School

GlobeNewswire

November 3, 2025

Canadians are feeling financially anxious as economic uncertainty persists

GlobeNewswire

November 3, 2025

Cognosos Earns AutoTech Breakthrough Award for Transportation Logistics Management Solution

GlobeNewswire

November 3, 2025

Ilia Malinin Shatters World Record at Skate Canada — U.S. Olympic Hopeful Brings His Historic Performance to Philadelphia December 13

GlobeNewswire

November 3, 2025

Cellectis to Present a Development Update for eti-cel at ASH 2025

GlobeNewswire

$Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting$

November 3, 2025

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

GlobeNewswire

November 3, 2025

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting

GlobeNewswire

November 3, 2025

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

GlobeNewswire

November 3, 2025

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting

GlobeNewswire

$SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting$

November 3, 2025

SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

November 3, 2025

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

GlobeNewswire

November 3, 2025

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition

GlobeNewswire

November 3, 2025

Introducing Magic InBra™: Medela’s Lightest and Most Advanced Wearable Breast Pump in the U.S.

GlobeNewswire

November 3, 2025

AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue

GlobeNewswire

Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010

November 3, 2025

Beauty Press Releases: Press Releases

October 2025

November 2025

December 2025

Press releases published on November 3, 2025

Mira Aesthetic Cosmetic Surgery Center Supports Local Athletics with Charitable Donation to Corona del Mar High School

Canadians are feeling financially anxious as economic uncertainty persists

Cognosos Earns AutoTech Breakthrough Award for Transportation Logistics Management Solution

Ilia Malinin Shatters World Record at Skate Canada — U.S. Olympic Hopeful Brings His Historic Performance to Philadelphia December 13

Cellectis to Present a Development Update for eti-cel at ASH 2025

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting

SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition

Introducing Magic InBra™: Medela’s Lightest and Most Advanced Wearable Breast Pump in the U.S.

AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue

Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010

NetworkNewsAudio Announces Audio Press Release (APR) on Emerging Junior with High-Quality Mill, Mineral Project

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation

LiveOne (Nasdaq: LVO) Accelerates Revenue Growth with Intuizi AI, Driving Tesla Subscriber Conversions

Avalyn to Participate in Multiple Upcoming Investor Conferences in November

GigaCloud Technology Inc Recognized in TIME’s ‘America’s Growth Leaders 2026’ List